[PDF] European CHMP recommends new contraindication for telmisartan products (Micardis®, Micardis plus®)

Source:
European Medicines Agency - EMA
Publisher:
European Medicines Agency
Publication date:
26 April 2013

Abstract

The CHMP has adopted a positive opinion recommending adoption of the following new contraindication for telmisartan: The concomitant use of telmisartan with aliskiren is contraindicated in patients with diabetes mellitus or renal impairment (GFR <60 ml/min/1.73 m2).